Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sexually Transmitted Diseases (STD) Testing Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Chlamydia
1.2.3 Syphilis
1.2.4 Gonorrhea
1.2.5 Herpes Simplex Virus
1.2.6 Human Papilloma Virus
1.2.7 Human Immunodeficiency Virus
1.2.8 Others
1.3 Market by Application
1.3.1 Global Sexually Transmitted Diseases (STD) Testing Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Laboratory Testing
1.3.3 Point of Care (POC) Testing
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sexually Transmitted Diseases (STD) Testing Market Perspective (2018-2033)
2.2 Global Sexually Transmitted Diseases (STD) Testing Growth Trends by Region
2.2.1 Sexually Transmitted Diseases (STD) Testing Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Sexually Transmitted Diseases (STD) Testing Historic Market Size by Region (2018-2023)
2.2.3 Sexually Transmitted Diseases (STD) Testing Forecasted Market Size by Region (2024-2033)
2.3 Sexually Transmitted Diseases (STD) Testing Market Dynamics
2.3.1 Sexually Transmitted Diseases (STD) Testing Industry Trends
2.3.2 Sexually Transmitted Diseases (STD) Testing Market Drivers
2.3.3 Sexually Transmitted Diseases (STD) Testing Market Challenges
2.3.4 Sexually Transmitted Diseases (STD) Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Sexually Transmitted Diseases (STD) Testing by Players
3.1.1 Global Sexually Transmitted Diseases (STD) Testing Revenue by Players (2018-2023)
3.1.2 Global Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Players (2018-2023)
3.2 Global Sexually Transmitted Diseases (STD) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Sexually Transmitted Diseases (STD) Testing, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Sexually Transmitted Diseases (STD) Testing Market Concentration Ratio
3.4.1 Global Sexually Transmitted Diseases (STD) Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sexually Transmitted Diseases (STD) Testing Revenue in 2022
3.5 Global Key Players of Sexually Transmitted Diseases (STD) Testing Head office and Area Served
3.6 Global Key Players of Sexually Transmitted Diseases (STD) Testing, Product and Application
3.7 Global Key Players of Sexually Transmitted Diseases (STD) Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Sexually Transmitted Diseases (STD) Testing Breakdown Data by Type
4.1 Global Sexually Transmitted Diseases (STD) Testing Historic Market Size by Type (2018-2023)
4.2 Global Sexually Transmitted Diseases (STD) Testing Forecasted Market Size by Type (2024-2033)
5 Sexually Transmitted Diseases (STD) Testing Breakdown Data by Application
5.1 Global Sexually Transmitted Diseases (STD) Testing Historic Market Size by Application (2018-2023)
5.2 Global Sexually Transmitted Diseases (STD) Testing Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Sexually Transmitted Diseases (STD) Testing Market Size (2018-2033)
6.2 North America Sexually Transmitted Diseases (STD) Testing Market Size by Type
6.2.1 North America Sexually Transmitted Diseases (STD) Testing Market Size by Type (2018-2023)
6.2.2 North America Sexually Transmitted Diseases (STD) Testing Market Size by Type (2024-2033)
6.2.3 North America Sexually Transmitted Diseases (STD) Testing Market Share by Type (2018-2033)
6.3 North America Sexually Transmitted Diseases (STD) Testing Market Size by Application
6.3.1 North America Sexually Transmitted Diseases (STD) Testing Market Size by Application (2018-2023)
6.3.2 North America Sexually Transmitted Diseases (STD) Testing Market Size by Application (2024-2033)
6.3.3 North America Sexually Transmitted Diseases (STD) Testing Market Share by Application (2018-2033)
6.4 North America Sexually Transmitted Diseases (STD) Testing Market Size by Country
6.4.1 North America Sexually Transmitted Diseases (STD) Testing Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Sexually Transmitted Diseases (STD) Testing Market Size by Country (2018-2023)
6.4.3 North America Sexually Transmitted Diseases (STD) Testing Market Size by Country (2024-2033)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Sexually Transmitted Diseases (STD) Testing Market Size (2018-2033)
7.2 Europe Sexually Transmitted Diseases (STD) Testing Market Size by Type
7.2.1 Europe Sexually Transmitted Diseases (STD) Testing Market Size by Type (2018-2023)
7.2.2 Europe Sexually Transmitted Diseases (STD) Testing Market Size by Type (2024-2033)
7.2.3 Europe Sexually Transmitted Diseases (STD) Testing Market Share by Type (2018-2033)
7.3 Europe Sexually Transmitted Diseases (STD) Testing Market Size by Application
7.3.1 Europe Sexually Transmitted Diseases (STD) Testing Market Size by Application (2018-2023)
7.3.2 Europe Sexually Transmitted Diseases (STD) Testing Market Size by Application (2024-2033)
7.3.3 Europe Sexually Transmitted Diseases (STD) Testing Market Share by Application (2018-2033)
7.4 Europe Sexually Transmitted Diseases (STD) Testing Market Size by Country
7.4.1 Europe Sexually Transmitted Diseases (STD) Testing Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Sexually Transmitted Diseases (STD) Testing Market Size by Country (2018-2023)
7.4.3 Europe Sexually Transmitted Diseases (STD) Testing Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Sexually Transmitted Diseases (STD) Testing Market Size (2018-2033)
8.2 China Sexually Transmitted Diseases (STD) Testing Market Size by Type
8.2.1 China Sexually Transmitted Diseases (STD) Testing Market Size by Type (2018-2023)
8.2.2 China Sexually Transmitted Diseases (STD) Testing Market Size by Type (2024-2033)
8.2.3 China Sexually Transmitted Diseases (STD) Testing Market Share by Type (2018-2033)
8.3 China Sexually Transmitted Diseases (STD) Testing Market Size by Application
8.3.1 China Sexually Transmitted Diseases (STD) Testing Market Size by Application (2018-2023)
8.3.2 China Sexually Transmitted Diseases (STD) Testing Market Size by Application (2024-2033)
8.3.3 China Sexually Transmitted Diseases (STD) Testing Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Sexually Transmitted Diseases (STD) Testing Market Size (2018-2033)
9.2 Asia Sexually Transmitted Diseases (STD) Testing Market Size by Type
9.2.1 Asia Sexually Transmitted Diseases (STD) Testing Market Size by Type (2018-2023)
9.2.2 Asia Sexually Transmitted Diseases (STD) Testing Market Size by Type (2024-2033)
9.2.3 Asia Sexually Transmitted Diseases (STD) Testing Market Share by Type (2018-2033)
9.3 Asia Sexually Transmitted Diseases (STD) Testing Market Size by Application
9.3.1 Asia Sexually Transmitted Diseases (STD) Testing Market Size by Application (2018-2023)
9.3.2 Asia Sexually Transmitted Diseases (STD) Testing Market Size by Application (2024-2033)
9.3.3 Asia Sexually Transmitted Diseases (STD) Testing Market Share by Application (2018-2033)
9.4 Asia Sexually Transmitted Diseases (STD) Testing Market Size by Region
9.4.1 Asia Sexually Transmitted Diseases (STD) Testing Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Sexually Transmitted Diseases (STD) Testing Market Size by Region (2018-2023)
9.4.3 Asia Sexually Transmitted Diseases (STD) Testing Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Testing Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Type
10.2.1 Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Testing Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Application
10.3.1 Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Testing Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Country
10.4.1 Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 ROCHE HOLDINGS
11.1.1 ROCHE HOLDINGS Company Details
11.1.2 ROCHE HOLDINGS Business Overview
11.1.3 ROCHE HOLDINGS Sexually Transmitted Diseases (STD) Testing Introduction
11.1.4 ROCHE HOLDINGS Revenue in Sexually Transmitted Diseases (STD) Testing Business (2018-2023)
11.1.5 ROCHE HOLDINGS Recent Developments
11.2 BIOMERIEUX
11.2.1 BIOMERIEUX Company Details
11.2.2 BIOMERIEUX Business Overview
11.2.3 BIOMERIEUX Sexually Transmitted Diseases (STD) Testing Introduction
11.2.4 BIOMERIEUX Revenue in Sexually Transmitted Diseases (STD) Testing Business (2018-2023)
11.2.5 BIOMERIEUX Recent Developments
11.3 HOLOGIC
11.3.1 HOLOGIC Company Details
11.3.2 HOLOGIC Business Overview
11.3.3 HOLOGIC Sexually Transmitted Diseases (STD) Testing Introduction
11.3.4 HOLOGIC Revenue in Sexually Transmitted Diseases (STD) Testing Business (2018-2023)
11.3.5 HOLOGIC Recent Developments
11.4 BECTON DICKINSON
11.4.1 BECTON DICKINSON Company Details
11.4.2 BECTON DICKINSON Business Overview
11.4.3 BECTON DICKINSON Sexually Transmitted Diseases (STD) Testing Introduction
11.4.4 BECTON DICKINSON Revenue in Sexually Transmitted Diseases (STD) Testing Business (2018-2023)
11.4.5 BECTON DICKINSON Recent Developments
11.5 ORASURE
11.5.1 ORASURE Company Details
11.5.2 ORASURE Business Overview
11.5.3 ORASURE Sexually Transmitted Diseases (STD) Testing Introduction
11.5.4 ORASURE Revenue in Sexually Transmitted Diseases (STD) Testing Business (2018-2023)
11.5.5 ORASURE Recent Developments
11.6 DANAHER
11.6.1 DANAHER Company Details
11.6.2 DANAHER Business Overview
11.6.3 DANAHER Sexually Transmitted Diseases (STD) Testing Introduction
11.6.4 DANAHER Revenue in Sexually Transmitted Diseases (STD) Testing Business (2018-2023)
11.6.5 DANAHER Recent Developments
11.7 AFFYMETRIX
11.7.1 AFFYMETRIX Company Details
11.7.2 AFFYMETRIX Business Overview
11.7.3 AFFYMETRIX Sexually Transmitted Diseases (STD) Testing Introduction
11.7.4 AFFYMETRIX Revenue in Sexually Transmitted Diseases (STD) Testing Business (2018-2023)
11.7.5 AFFYMETRIX Recent Developments
11.8 ABBOTT LABORATORIES
11.8.1 ABBOTT LABORATORIES Company Details
11.8.2 ABBOTT LABORATORIES Business Overview
11.8.3 ABBOTT LABORATORIES Sexually Transmitted Diseases (STD) Testing Introduction
11.8.4 ABBOTT LABORATORIES Revenue in Sexually Transmitted Diseases (STD) Testing Business (2018-2023)
11.8.5 ABBOTT LABORATORIES Recent Developments
11.9 BIO-RAD LABORATORIES
11.9.1 BIO-RAD LABORATORIES Company Details
11.9.2 BIO-RAD LABORATORIES Business Overview
11.9.3 BIO-RAD LABORATORIES Sexually Transmitted Diseases (STD) Testing Introduction
11.9.4 BIO-RAD LABORATORIES Revenue in Sexually Transmitted Diseases (STD) Testing Business (2018-2023)
11.9.5 BIO-RAD LABORATORIES Recent Developments
11.10 DIASORIN
11.10.1 DIASORIN Company Details
11.10.2 DIASORIN Business Overview
11.10.3 DIASORIN Sexually Transmitted Diseases (STD) Testing Introduction
11.10.4 DIASORIN Revenue in Sexually Transmitted Diseases (STD) Testing Business (2018-2023)
11.10.5 DIASORIN Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Sexually Transmitted Diseases (STD) Testing Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Chlamydia
Table 3. Key Players of Syphilis
Table 4. Key Players of Gonorrhea
Table 5. Key Players of Herpes Simplex Virus
Table 6. Key Players of Human Papilloma Virus
Table 7. Key Players of Human Immunodeficiency Virus
Table 8. Key Players of Others
Table 9. Global Sexually Transmitted Diseases (STD) Testing Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 10. Global Sexually Transmitted Diseases (STD) Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 11. Global Sexually Transmitted Diseases (STD) Testing Market Size by Region (2018-2023) & (US$ Million)
Table 12. Global Sexually Transmitted Diseases (STD) Testing Market Share by Region (2018-2023)
Table 13. Global Sexually Transmitted Diseases (STD) Testing Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 14. Global Sexually Transmitted Diseases (STD) Testing Market Share by Region (2024-2033)
Table 15. Sexually Transmitted Diseases (STD) Testing Market Trends
Table 16. Sexually Transmitted Diseases (STD) Testing Market Drivers
Table 17. Sexually Transmitted Diseases (STD) Testing Market Challenges
Table 18. Sexually Transmitted Diseases (STD) Testing Market Restraints
Table 19. Global Sexually Transmitted Diseases (STD) Testing Revenue by Players (2018-2023) & (US$ Million)
Table 20. Global Sexually Transmitted Diseases (STD) Testing Revenue Share by Players (2018-2023)
Table 21. Global Top Sexually Transmitted Diseases (STD) Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sexually Transmitted Diseases (STD) Testing as of 2022)
Table 22. Global Sexually Transmitted Diseases (STD) Testing Industry Ranking 2021 VS 2022 VS 2023
Table 23. Global 5 Largest Players Market Share by Sexually Transmitted Diseases (STD) Testing Revenue (CR5 and HHI) & (2018-2023)
Table 24. Global Key Players of Sexually Transmitted Diseases (STD) Testing, Headquarters and Area Served
Table 25. Global Key Players of Sexually Transmitted Diseases (STD) Testing, Product and Application
Table 26. Global Key Players of Sexually Transmitted Diseases (STD) Testing, Product and Application
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Sexually Transmitted Diseases (STD) Testing Market Size by Type (2018-2023) & (US$ Million)
Table 29. Global Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Type (2018-2023)
Table 30. Global Sexually Transmitted Diseases (STD) Testing Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 31. Global Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Type (2024-2033)
Table 32. Global Sexually Transmitted Diseases (STD) Testing Market Size by Application (2018-2023) & (US$ Million)
Table 33. Global Sexually Transmitted Diseases (STD) Testing Revenue Share by Application (2018-2023)
Table 34. Global Sexually Transmitted Diseases (STD) Testing Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 35. Global Sexually Transmitted Diseases (STD) Testing Revenue Share by Application (2024-2033)
Table 36. North America Sexually Transmitted Diseases (STD) Testing Market Size by Type (2018-2023) & (US$ Million)
Table 37. North America Sexually Transmitted Diseases (STD) Testing Market Size by Type (2024-2033) & (US$ Million)
Table 38. North America Sexually Transmitted Diseases (STD) Testing Market Size by Application (2018-2023) & (US$ Million)
Table 39. North America Sexually Transmitted Diseases (STD) Testing Market Size by Application (2024-2033) & (US$ Million)
Table 40. North America Sexually Transmitted Diseases (STD) Testing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. North America Sexually Transmitted Diseases (STD) Testing Market Size by Country (2018-2023) & (US$ Million)
Table 42. North America Sexually Transmitted Diseases (STD) Testing Market Size by Country (2024-2033) & (US$ Million)
Table 43. Europe Sexually Transmitted Diseases (STD) Testing Market Size by Type (2018-2023) & (US$ Million)
Table 44. Europe Sexually Transmitted Diseases (STD) Testing Market Size by Type (2024-2033) & (US$ Million)
Table 45. Europe Sexually Transmitted Diseases (STD) Testing Market Size by Application (2018-2023) & (US$ Million)
Table 46. Europe Sexually Transmitted Diseases (STD) Testing Market Size by Application (2024-2033) & (US$ Million)
Table 47. Europe Sexually Transmitted Diseases (STD) Testing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 48. Europe Sexually Transmitted Diseases (STD) Testing Market Size by Country (2018-2023) & (US$ Million)
Table 49. Europe Sexually Transmitted Diseases (STD) Testing Market Size by Country (2024-2033) & (US$ Million)
Table 50. China Sexually Transmitted Diseases (STD) Testing Market Size by Type (2018-2023) & (US$ Million)
Table 51. China Sexually Transmitted Diseases (STD) Testing Market Size by Type (2024-2033) & (US$ Million)
Table 52. China Sexually Transmitted Diseases (STD) Testing Market Size by Application (2018-2023) & (US$ Million)
Table 53. China Sexually Transmitted Diseases (STD) Testing Market Size by Application (2024-2033) & (US$ Million)
Table 54. Asia Sexually Transmitted Diseases (STD) Testing Market Size by Type (2018-2023) & (US$ Million)
Table 55. Asia Sexually Transmitted Diseases (STD) Testing Market Size by Type (2024-2033) & (US$ Million)
Table 56. Asia Sexually Transmitted Diseases (STD) Testing Market Size by Application (2018-2023) & (US$ Million)
Table 57. Asia Sexually Transmitted Diseases (STD) Testing Market Size by Application (2024-2033) & (US$ Million)
Table 58. Asia Sexually Transmitted Diseases (STD) Testing Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 59. Asia Sexually Transmitted Diseases (STD) Testing Market Size by Region (2018-2023) & (US$ Million)
Table 60. Asia Sexually Transmitted Diseases (STD) Testing Market Size by Region (2024-2033) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Type (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Type (2024-2033) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Application (2018-2023) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Application (2024-2033) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Testing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 66. Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Country (2018-2023) & (US$ Million)
Table 67. Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Country (2024-2033) & (US$ Million)
Table 68. ROCHE HOLDINGS Company Details
Table 69. ROCHE HOLDINGS Business Overview
Table 70. ROCHE HOLDINGS Sexually Transmitted Diseases (STD) Testing Product
Table 71. ROCHE HOLDINGS Revenue in Sexually Transmitted Diseases (STD) Testing Business (2018-2023) & (US$ Million)
Table 72. ROCHE HOLDINGS Recent Developments
Table 73. BIOMERIEUX Company Details
Table 74. BIOMERIEUX Business Overview
Table 75. BIOMERIEUX Sexually Transmitted Diseases (STD) Testing Product
Table 76. BIOMERIEUX Revenue in Sexually Transmitted Diseases (STD) Testing Business (2018-2023) & (US$ Million)
Table 77. BIOMERIEUX Recent Developments
Table 78. HOLOGIC Company Details
Table 79. HOLOGIC Business Overview
Table 80. HOLOGIC Sexually Transmitted Diseases (STD) Testing Product
Table 81. HOLOGIC Revenue in Sexually Transmitted Diseases (STD) Testing Business (2018-2023) & (US$ Million)
Table 82. HOLOGIC Recent Developments
Table 83. BECTON DICKINSON Company Details
Table 84. BECTON DICKINSON Business Overview
Table 85. BECTON DICKINSON Sexually Transmitted Diseases (STD) Testing Product
Table 86. BECTON DICKINSON Revenue in Sexually Transmitted Diseases (STD) Testing Business (2018-2023) & (US$ Million)
Table 87. BECTON DICKINSON Recent Developments
Table 88. ORASURE Company Details
Table 89. ORASURE Business Overview
Table 90. ORASURE Sexually Transmitted Diseases (STD) Testing Product
Table 91. ORASURE Revenue in Sexually Transmitted Diseases (STD) Testing Business (2018-2023) & (US$ Million)
Table 92. ORASURE Recent Developments
Table 93. DANAHER Company Details
Table 94. DANAHER Business Overview
Table 95. DANAHER Sexually Transmitted Diseases (STD) Testing Product
Table 96. DANAHER Revenue in Sexually Transmitted Diseases (STD) Testing Business (2018-2023) & (US$ Million)
Table 97. DANAHER Recent Developments
Table 98. AFFYMETRIX Company Details
Table 99. AFFYMETRIX Business Overview
Table 100. AFFYMETRIX Sexually Transmitted Diseases (STD) Testing Product
Table 101. AFFYMETRIX Revenue in Sexually Transmitted Diseases (STD) Testing Business (2018-2023) & (US$ Million)
Table 102. AFFYMETRIX Recent Developments
Table 103. ABBOTT LABORATORIES Company Details
Table 104. ABBOTT LABORATORIES Business Overview
Table 105. ABBOTT LABORATORIES Sexually Transmitted Diseases (STD) Testing Product
Table 106. ABBOTT LABORATORIES Revenue in Sexually Transmitted Diseases (STD) Testing Business (2018-2023) & (US$ Million)
Table 107. ABBOTT LABORATORIES Recent Developments
Table 108. BIO-RAD LABORATORIES Company Details
Table 109. BIO-RAD LABORATORIES Business Overview
Table 110. BIO-RAD LABORATORIES Sexually Transmitted Diseases (STD) Testing Product
Table 111. BIO-RAD LABORATORIES Revenue in Sexually Transmitted Diseases (STD) Testing Business (2018-2023) & (US$ Million)
Table 112. BIO-RAD LABORATORIES Recent Developments
Table 113. DIASORIN Company Details
Table 114. DIASORIN Business Overview
Table 115. DIASORIN Sexually Transmitted Diseases (STD) Testing Product
Table 116. DIASORIN Revenue in Sexually Transmitted Diseases (STD) Testing Business (2018-2023) & (US$ Million)
Table 117. DIASORIN Recent Developments
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sexually Transmitted Diseases (STD) Testing Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Sexually Transmitted Diseases (STD) Testing Market Share by Type: 2022 VS 2033
Figure 3. Chlamydia Features
Figure 4. Syphilis Features
Figure 5. Gonorrhea Features
Figure 6. Herpes Simplex Virus Features
Figure 7. Human Papilloma Virus Features
Figure 8. Human Immunodeficiency Virus Features
Figure 9. Others Features
Figure 10. Global Sexually Transmitted Diseases (STD) Testing Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 11. Global Sexually Transmitted Diseases (STD) Testing Market Share by Application: 2022 VS 2033
Figure 12. Laboratory Testing Case Studies
Figure 13. Point of Care (POC) Testing Case Studies
Figure 14. Sexually Transmitted Diseases (STD) Testing Report Years Considered
Figure 15. Global Sexually Transmitted Diseases (STD) Testing Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 16. Global Sexually Transmitted Diseases (STD) Testing Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 17. Global Sexually Transmitted Diseases (STD) Testing Market Share by Region: 2022 VS 2033
Figure 18. Global Sexually Transmitted Diseases (STD) Testing Market Share by Players in 2022
Figure 19. Global Top Sexually Transmitted Diseases (STD) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sexually Transmitted Diseases (STD) Testing as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Sexually Transmitted Diseases (STD) Testing Revenue in 2022
Figure 21. North America Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. North America Sexually Transmitted Diseases (STD) Testing Market Share by Type (2018-2033)
Figure 23. North America Sexually Transmitted Diseases (STD) Testing Market Share by Application (2018-2033)
Figure 24. North America Sexually Transmitted Diseases (STD) Testing Market Share by Country (2018-2033)
Figure 25. United States Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Canada Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Europe Sexually Transmitted Diseases (STD) Testing Market Size YoY (2018-2033) & (US$ Million)
Figure 28. Europe Sexually Transmitted Diseases (STD) Testing Market Share by Type (2018-2033)
Figure 29. Europe Sexually Transmitted Diseases (STD) Testing Market Share by Application (2018-2033)
Figure 30. Europe Sexually Transmitted Diseases (STD) Testing Market Share by Country (2018-2033)
Figure 31. Germany Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. France Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. U.K. Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Italy Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Russia Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Nordic Countries Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. China Sexually Transmitted Diseases (STD) Testing Market Size YoY (2018-2033) & (US$ Million)
Figure 38. China Sexually Transmitted Diseases (STD) Testing Market Share by Type (2018-2033)
Figure 39. China Sexually Transmitted Diseases (STD) Testing Market Share by Application (2018-2033)
Figure 40. Asia Sexually Transmitted Diseases (STD) Testing Market Size YoY (2018-2033) & (US$ Million)
Figure 41. Asia Sexually Transmitted Diseases (STD) Testing Market Share by Type (2018-2033)
Figure 42. Asia Sexually Transmitted Diseases (STD) Testing Market Share by Application (2018-2033)
Figure 43. Asia Sexually Transmitted Diseases (STD) Testing Market Share by Region (2018-2033)
Figure 44. Japan Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. South Korea Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. China Taiwan Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Southeast Asia Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. India Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Australia Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Testing Market Size YoY (2018-2033) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Testing Market Share by Type (2018-2033)
Figure 52. Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Testing Market Share by Application (2018-2033)
Figure 53. Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Testing Market Share by Country (2018-2033)
Figure 54. Brazil Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Mexico Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Turkey Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Saudi Arabia Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. Israel Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 59. GCC Countries Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 60. ROCHE HOLDINGS Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2018-2023)
Figure 61. BIOMERIEUX Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2018-2023)
Figure 62. HOLOGIC Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2018-2023)
Figure 63. BECTON DICKINSON Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2018-2023)
Figure 64. ORASURE Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2018-2023)
Figure 65. DANAHER Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2018-2023)
Figure 66. AFFYMETRIX Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2018-2023)
Figure 67. ABBOTT LABORATORIES Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2018-2023)
Figure 68. BIO-RAD LABORATORIES Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2018-2023)
Figure 69. DIASORIN Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2018-2023)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed